{
  "input": {
    "mode": "score",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        }
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        }
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        }
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_atorvastatin",
          "name": "Atorvastatin"
        }
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_simvastatin",
          "name": "Simvastatin"
        }
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        }
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        }
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        }
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_mipomersen",
          "name": "Mipomersen"
        }
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_barricade",
          "name": "Barricade"
        }
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_alirocumab",
          "name": "Alirocumab"
        }
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_cevostamab",
          "name": "Cevostamab"
        }
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atorvastatin",
          "type": "Drug",
          "label": "Atorvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_simvastatin",
          "type": "Drug",
          "label": "Simvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_omega_3_fatty_acids",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mipomersen",
          "type": "Drug",
          "label": "Mipomersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_barricade",
          "type": "Drug",
          "label": "Barricade",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_alirocumab",
          "type": "Drug",
          "label": "Alirocumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cevostamab",
          "type": "Drug",
          "label": "Cevostamab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_lipid_metabolism",
          "type": "Target",
          "label": "Lipid Metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_lipid_regulation",
          "type": "Pathway",
          "label": "Lipid Regulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe Hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_fenofibrate",
          "type": "Target",
          "label": "OffTargetFenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_fenofibrate",
          "type": "Pathway",
          "label": "RiskPathwayFenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_fenofibrate",
          "type": "Phenotype",
          "label": "AdversePhenotypeFenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_gemfibrozil",
          "type": "Target",
          "label": "OffTargetGemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_gemfibrozil",
          "type": "Pathway",
          "label": "RiskPathwayGemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_gemfibrozil",
          "type": "Phenotype",
          "label": "AdversePhenotypeGemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_niacin",
          "type": "Target",
          "label": "OffTargetNiacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_niacin",
          "type": "Pathway",
          "label": "RiskPathwayNiacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_niacin",
          "type": "Phenotype",
          "label": "AdversePhenotypeNiacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_atorvastatin",
          "type": "Target",
          "label": "OffTargetAtorvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_atorvastatin",
          "type": "Pathway",
          "label": "RiskPathwayAtorvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_atorvastatin",
          "type": "Phenotype",
          "label": "AdversePhenotypeAtorvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_simvastatin",
          "type": "Target",
          "label": "OffTargetSimvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_simvastatin",
          "type": "Pathway",
          "label": "RiskPathwaySimvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_simvastatin",
          "type": "Phenotype",
          "label": "AdversePhenotypeSimvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ezetimibe",
          "type": "Target",
          "label": "OffTargetEzetimibe",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ezetimibe",
          "type": "Pathway",
          "label": "RiskPathwayEzetimibe",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ezetimibe",
          "type": "Phenotype",
          "label": "AdversePhenotypeEzetimibe",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_omega_3",
          "type": "Target",
          "label": "OffTargetOmega3",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_omega_3",
          "type": "Pathway",
          "label": "RiskPathwayOmega3",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_omega_3",
          "type": "Phenotype",
          "label": "AdversePhenotypeOmega3",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lomitapide",
          "type": "Target",
          "label": "OffTargetLomitapide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_lomitapide",
          "type": "Pathway",
          "label": "RiskPathwayLomitapide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_lomitapide",
          "type": "Phenotype",
          "label": "AdversePhenotypeLomitapide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_mipomersen",
          "type": "Target",
          "label": "OffTargetMipomersen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_mipomersen",
          "type": "Pathway",
          "label": "RiskPathwayMipomersen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_mipomersen",
          "type": "Phenotype",
          "label": "AdversePhenotypeMipomersen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_barricade",
          "type": "Target",
          "label": "OffTargetBarricade",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_barricade",
          "type": "Pathway",
          "label": "RiskPathwayBarricade",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_barricade",
          "type": "Phenotype",
          "label": "AdversePhenotypeBarricade",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_alirocumab",
          "type": "Target",
          "label": "OffTargetAlirocumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_alirocumab",
          "type": "Pathway",
          "label": "RiskPathwayAlirocumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_alirocumab",
          "type": "Phenotype",
          "label": "AdversePhenotypeAlirocumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cevostamab",
          "type": "Target",
          "label": "OffTargetCevostamab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cevostamab",
          "type": "Pathway",
          "label": "RiskPathwayCevostamab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cevostamab",
          "type": "Phenotype",
          "label": "AdversePhenotypeCevostamab",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_fenofibrate",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Fenofibrate常用于调节脂代谢"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Gemfibrozil具有明显的脂质调节作用"
        },
        {
          "source": "drug_niacin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Niacin已知影响脂质水平"
        },
        {
          "source": "drug_atorvastatin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Atorvastatin有效降低血液脂肪"
        },
        {
          "source": "drug_simvastatin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Simvastatin对脂肪代谢有影响"
        },
        {
          "source": "drug_ezetimibe",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Ezetimibe通过抑制胆固醇吸收调节脂质"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Omega-3脂肪酸可降低甘油三酯"
        },
        {
          "source": "drug_lomitapide",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Lomitapide用于特定脂质紊乱"
        },
        {
          "source": "drug_mipomersen",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Mipomersen针对特定脂质代谢问题"
        },
        {
          "source": "drug_barricade",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Barricade也与脂质过程相关"
        },
        {
          "source": "drug_alirocumab",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Alirocumab用于LDL调节，因此关联"
        },
        {
          "source": "drug_cevostamab",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Cevostamab与脂质代谢潜在关联"
        },
        {
          "source": "target_lipid_metabolism",
          "target": "pathway_lipid_regulation",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "脂质代谢与调控通路密切关联"
        },
        {
          "source": "pathway_lipid_regulation",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "脂质调控影响甘油三酯水平"
        },
        {
          "source": "drug_fenofibrate",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Fenofibrate对严重高甘油三酯血症的有效性"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Gemfibrozil用于管理高甘油三酯水平"
        },
        {
          "source": "drug_niacin",
          "target": "H3",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Niacin已证明降低甘油三酯"
        },
        {
          "source": "drug_atorvastatin",
          "target": "H4",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Atorvastatin用于高脂血症"
        },
        {
          "source": "drug_simvastatin",
          "target": "H5",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Simvastatin作为降脂药物有效"
        },
        {
          "source": "drug_ezetimibe",
          "target": "H6",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Ezetimibe调节胆固醇吸收"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "H7",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Omega-3降低甘油三酯常识"
        },
        {
          "source": "drug_lomitapide",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Lomitapide用于特定高甘油三酯状况"
        },
        {
          "source": "drug_mipomersen",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Mipomersen在管理高脂血症中应用"
        },
        {
          "source": "drug_barricade",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Barricade在脂质调节方面的潜力"
        },
        {
          "source": "drug_alirocumab",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Alirocumab对脂质调节的作用"
        },
        {
          "source": "drug_cevostamab",
          "target": "H12",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Cevostamab与脂质代谢有潜在联系"
        },
        {
          "source": "drug_fenofibrate",
          "target": "n_ot_fenofibrate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_fenofibrate",
          "target": "n_rp_fenofibrate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_fenofibrate",
          "target": "n_adv_fenofibrate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_fenofibrate",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "n_ot_gemfibrozil",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_gemfibrozil",
          "target": "n_rp_gemfibrozil",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_gemfibrozil",
          "target": "n_adv_gemfibrozil",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_gemfibrozil",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_niacin",
          "target": "n_ot_niacin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_niacin",
          "target": "n_rp_niacin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_niacin",
          "target": "n_adv_niacin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_niacin",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_atorvastatin",
          "target": "n_ot_atorvastatin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_atorvastatin",
          "target": "n_rp_atorvastatin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_atorvastatin",
          "target": "n_adv_atorvastatin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_atorvastatin",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_simvastatin",
          "target": "n_ot_simvastatin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_simvastatin",
          "target": "n_rp_simvastatin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_simvastatin",
          "target": "n_adv_simvastatin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_simvastatin",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_ezetimibe",
          "target": "n_ot_ezetimibe",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_ezetimibe",
          "target": "n_rp_ezetimibe",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_ezetimibe",
          "target": "n_adv_ezetimibe",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_ezetimibe",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "n_ot_omega_3",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_omega_3",
          "target": "n_rp_omega_3",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_omega_3",
          "target": "n_adv_omega_3",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_omega_3",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_lomitapide",
          "target": "n_ot_lomitapide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_lomitapide",
          "target": "n_rp_lomitapide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_lomitapide",
          "target": "n_adv_lomitapide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_lomitapide",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_mipomersen",
          "target": "n_ot_mipomersen",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_mipomersen",
          "target": "n_rp_mipomersen",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_mipomersen",
          "target": "n_adv_mipomersen",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_mipomersen",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_barricade",
          "target": "n_ot_barricade",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_barricade",
          "target": "n_rp_barricade",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_barricade",
          "target": "n_adv_barricade",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_barricade",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_alirocumab",
          "target": "n_ot_alirocumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_alirocumab",
          "target": "n_rp_alirocumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_alirocumab",
          "target": "n_adv_alirocumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_alirocumab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        },
        {
          "source": "drug_cevostamab",
          "target": "n_ot_cevostamab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶点"
        },
        {
          "source": "n_ot_cevostamab",
          "target": "n_rp_cevostamab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "未知风险通路可能参与"
        },
        {
          "source": "n_rp_cevostamab",
          "target": "n_adv_cevostamab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在造成不良表型"
        },
        {
          "source": "n_adv_cevostamab",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能抵消疗效"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": []
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "scoring_summary": [
      {
        "hypothesis_id": "H1",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.06
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Fenofibrate",
              "pro": [
                "H1"
              ],
              "con": [
                "n_adv_fenofibrate"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Fenofibrate通过脂质代谢靶向机制，影响甘油三酯水平"
          ],
          "safety_risk": [
            "Skeptic 指出可能引发不良表型"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "安全性与疗效之间的权衡需要进一步验证"
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.06
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Gemfibrozil",
              "pro": [
                "H2"
              ],
              "con": [
                "n_adv_gemfibrozil"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Gemfibrozil通过脂质代谢靶向机制，有效降低甘油三酯"
          ],
          "safety_risk": [
            "Skeptic 提出潜在的不良反应限制了其用途"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "不良反应与疗效之间的冲突"
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.06
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Niacin",
              "pro": [
                "H3"
              ],
              "con": [
                "n_adv_niacin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Niacin通过影响脂质水平，减轻高甘油三酯血症"
          ],
          "safety_risk": [
            "Skeptic 指出潜在的不良效应"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "疗效与安全性间的相关性待验证"
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.6,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Atorvastatin",
              "pro": [
                "H4"
              ],
              "con": [
                "n_adv_atorvastatin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Atorvastatin有效降低甘油三酯水平"
          ],
          "safety_risk": [
            "Skeptic 提出可能的副作用抑制效果"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "长期使用的安全性"
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.6,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Simvastatin",
              "pro": [
                "H5"
              ],
              "con": [
                "n_adv_simvastatin"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Simvastatin通过影响脂质水平，缓解高甘油三酯血症"
          ],
          "safety_risk": [
            "Skeptic 提出潜在副作用限制"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "长期安全性数据不足"
        ]
      },
      {
        "hypothesis_id": "H6",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Ezetimibe",
              "pro": [
                "H6"
              ],
              "con": [
                "n_adv_ezetimibe"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Ezetimibe通过影响胆固醇吸收来调节脂质水平"
          ],
          "safety_risk": [
            "存在潜在的副作用"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "缺乏长期疗效和安全性数据"
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Omega-3 fatty acids",
              "pro": [
                "H7"
              ],
              "con": [
                "n_adv_omega_3"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Omega-3 fatty酸通过脂质调节作用降低甘油三酯"
          ],
          "safety_risk": [
            "可能影响非靶表型"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "缺乏证据支持长期使用的安全性"
        ]
      },
      {
        "hypothesis_id": "H8",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Lomitapide",
              "pro": [
                "H8"
              ],
              "con": [
                "n_adv_lomitapide"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Lomitapide用于特定的脂质紊乱管理"
          ],
          "safety_risk": [
            "Skeptic 指出可能的副作用"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "相关不良反应与疗效关系不明确"
        ]
      },
      {
        "hypothesis_id": "H9",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.5,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Mipomersen",
              "pro": [
                "H9"
              ],
              "con": [
                "n_adv_mipomersen"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Mipomersen用于针对特定的脂质代谢问题"
          ],
          "safety_risk": [
            "存在不少潜在不良反应"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "疗效与安全性的证据有待补充"
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.45,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Barricade",
              "pro": [
                "H10"
              ],
              "con": [
                "n_adv_barricade"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Barricade可能影响脂质过程"
          ],
          "safety_risk": [
            "存在显著不良反应混淆疗效"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "疗效与副作用需要进一步验证"
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.45,
          "safety_risk": 0.5,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Alirocumab",
              "pro": [
                "H11"
              ],
              "con": [
                "n_adv_alirocumab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Alirocumab用于LDL调节，间接影响甘油三酯"
          ],
          "safety_risk": [
            "不良反应需更多研究"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "疗效支持有限且有潜在副作用"
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.4,
        "components": {
          "mechanism_fit": 0.45,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.4,
          "safety_risk": 0.5,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.45,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Adverse effects of Cevostamab",
              "pro": [
                "H12"
              ],
              "con": [
                "n_adv_cevostamab"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Cevostamab与脂质代谢有潜在联系"
          ],
          "safety_risk": [
            "缺乏相关副作用研究"
          ]
        },
        "confidence": "medium",
        "uncertainties": [
          "疗效与安全性资料不足"
        ]
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "delta_since_last_round": 0.05,
    "stop_decision": {
      "should_stop": false,
      "reasons": [
        "Δscore≥0.03"
      ]
    }
  }
}